Showing results (81-90 of 5,290) with videos related to
Sort By:
Pageof 529
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2N S Magnuson, L E Perryman, C R Wyatt, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1993
Antitumor response to recombinant murine interferon gamma correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophagesP L Black, H Phillips, H R Tribble, et al.Cancer Research|March 1, 1985
Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcelluloseJ E Talmadge, J Adams, H Phillips, et al.Cancer Gene Therapy|April 19, 2000
Purging of human breast cancer cells from stem cell products with an adenovirus containing p53M Hirai, L S Kelsey, M Vaillancourt, et al.Journal of the National Cancer Institute|June 1, 1987
In vivo immunologic selection of class I major histocompatibility complex gene deletion variants from the B16-BL6 melanomaJ E Talmadge, C B Talmadge, B Zbar, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1988
Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent modelsM P Castelli, P L Black, M Schneider, et al.Experimental Hematology|January 16, 1998
Cell adhesion molecule expression on CD34+ cells in grafts and time to myeloid and platelet recovery after autologous stem cell transplantationT Watanabe, B Dave, D G Heimann, et al.Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Growth factor mobilization and modulation of progenitor cell adhesion to stromal cells: role of VLA-4B Dave, T Watanabe, R K Singh, et al.Infection and Immunity|November 1, 1978
Synthesis of DNA and protein by Anaplasma marginale in bovine erythrocytes during short-term cultureW C Davis, J E Talmadge, S M Parish, et al.International Journal of Immunopharmacology|May 1, 1992
Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitroH Fujii, T Takada, K Nemoto, et al.Pageof 529